Process and Outcome Evaluation of Different Psychotherapies
Launched by UNIVERSITY OF SALZBURG · Aug 2, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients: indication for psychotherapy, adult patients capable of giving consent, with sufficient knowledge of German to complete the questionnaires, signed treatment contract and declaration of consent
- • Psychotherapists: officially registered psychotherapists and psychotherapists in training under supervision (in Austria), signed work contract and declaration of consent
About University Of Salzburg
The University of Salzburg, a distinguished institution in Austria, is committed to advancing medical research and clinical innovation through its clinical trial sponsorship. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its expertise in various fields, including medicine, psychology, and health sciences, to facilitate impactful studies that enhance patient care and health outcomes. The University of Salzburg prioritizes ethical standards and regulatory compliance, ensuring that all trials contribute valuable insights to the scientific community while maintaining the highest levels of participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salzburg, , Austria
Patients applied
Trial Officials
Thomas Probst, Univ.Prof.Dr
Study Director
Paris-Lodron-University Salzburg
Franziska Pfannerstill, Dr.
Principal Investigator
Paris-Lodron-University Salzburg
Hannah van Alebeek, Dr.
Principal Investigator
Paris-Lodron-University Salzburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported